Authors: Tagat, JR McCombie, SW Steensma, RW Lin, SI Nazareno, DV Baroudy, B Vantuno, N Xu, S Liu, J

Citation: Jr. Tagat et al., Piperazine-based CCR5 antagonists as HIV-1 inhibitors. I: 2(S)-methyl piperazine as a key pharmacophore element, BIOORG MED, 11(16), 2001, pp. 2143-2146

Authors: Tagat, JR Steensma, RW McCombie, SW Nazareno, DV Lin, SI Neustadt, BR Cox, K Xu, S Wojcik, L Murray, MG Vantuno, N Baroudy, BM Strizki, JM

Citation: Jr. Tagat et al., Piperazine-based CCR5 antagonists as HIV-1 inhibitors. II. Discovery of 1-[(2,4-dimethyl-3-pyridinyl)carbonyl]-4-methyl-4-[3(S)-methyl-4-[1(S)-[4-(trifluoro-methyl)phenyl]ethyl]-1-piperazinyl]-piperidine N1-oxide (Sch-350634), an orally bioavailable, potent CCR5 antagonist, J MED CHEM, 44(21), 2001, pp. 3343-3346

Authors: Shiau, CY Chen, S Tsai, JC Lin, SI

Citation: Cy. Shiau et al., Effect of zinc addition on copper catalyst in isoamyl alcohol dehydrogenation, APP CATAL A, 198(1-2), 2000, pp. 95-102

Authors: McCombie, SW Lin, SI Vice, SF

Citation: Sw. Mccombie et al., New reactions of hydrazides. Part 1: Directed ortho- and lateral metalation of aromatic carbocyclic and heterocyclic systems, TETRAHEDR L, 40(50), 1999, pp. 8767-8770